HIMS
$22.02-2.14 (-8.86%)
Hims & Hers Health, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-pre...
Recent News
Hims & Hers (HIMS) Tumbles 8.86% on Market Bloodbath, Profit-Taking
Hims & Hers Health Inc. (NYSE:HIMS) is one of the 10 Stock Market Casualties You Can’t Ignore Today. Hims & Hers fell by 8.86 percent on Friday to close at $22.02 apiece, as investors unloaded positions amid a combination of market pessimism and profit-taking, having soared by as much as 88 percent already this month. […]
Does Hims & Hers (HIMS) Novo Nordisk Deal Quietly Redraw Its Risk Reward Profile?
Earlier in March 2026, Novo Nordisk agreed to resume selling its weight-loss drugs through the Hims & Hers Health platform, ending a public legal conflict over copycat medications and restoring a commercial relationship in one of healthcare’s most competitive categories. Days later, Hims & Hers appointed veteran communicator Kathryn Beiser as Chief Communications Officer, underscoring the company’s focus on strengthening its brand and explaining its broader telehealth ambitions to...
Why The Hims & Hers Health (HIMS) Story Is Resetting After Novo Deal And New Guidance
The modeled fair value for Hims & Hers Health has been revised from about US$44.36 to around US$23.69, a reset of roughly 47% in the price target framework. This shift aligns with Street commentary that balances enthusiasm around the renewed Novo Nordisk GLP-1 agreement with concerns related to recent results, 2026 guidance, legal and regulatory risk, and execution on new offerings. As you read on, you will see how these factors shape the evolving analyst narrative and what to watch...
1 Growth Stock with All-Star Potential and 2 That Underwhelm
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $23.15, indicating a -7.33% shift from the previous trading day.